Kathy Miller

Has grant

Indiana University Bloomington

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Exploiting unique biology to improve outcome for black patients with breast cancer.

Open Date: 2024-10-01

Close Date: 2025-09-30

Grant: Close

Exploiting unique biology to improve outcome for black patients with breast cancer.

Open Date: 2023-10-01

Close Date: 2024-09-30

Grant: Close

Combination therapies for TONSL expressing breast cancer

Open Date: 2022-10-01

Close Date: 2023-09-30

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (2)

Carolina Reduzzi

Assistant Professor

Weill Cornell Medicine

UNITED STATES

View details

Yara G Abdou

University of North Carolina at Chapel Hill

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Kathy Miller

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (10)

Circulating Tumor Cell Dynamics after CDK4/6 Inhibitor for Hormone Receptor–Positive Metastatic Breast Cancer: A Biomarker Analysis from the PACE Phase II Study

Guidance for JCO Authors on Subgroup Representation and Reporting

Development of a multi-institutional dataset to validate a novel inflammatory breast cancer diagnostic score

Randomized Controlled Trial of Acceptance and Commitment Therapy for Fatigue Interference With Functioning in Metastatic Breast Cancer

PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor–Negative Metastatic Breast Cancer

Flashback Foreword: Supervised Risk Predictor of Breast Cancer

A New Look as JCO Looks to the Future

Use of Large Language Models and Artificial Intelligence Tools in Works Submitted to Journal of Clinical Oncology

TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer.

ASCO Living Guidelines: The Next Frontier

Collaborators (2)

Carolina Reduzzi

Yara G Abdou

Make your next move.